Chief Executive of pain specialists Purdue Pharma Mark Timney talks to the Pharma Letter’s Katie Osborne about the company’s hopes and ambitions to move away fr 19 April 2016
Senior director of business development at the US-based company, Ultragenyx, Rob Anstey, takes time out of his busy schedule at the recent Bio Europe spring con 7 April 2016
GlaxoSmithKline's head of worldwide medical affairs Danie du Plessie, speaks exclusively to the Pharma Letter's Katie Osborne during the 14th annual eyeforpharm 16 March 2016
The newly-appointed chief executive of US-based firm Avanir Pharmaceuticals has set out his vision in an exclusive interview with the Pharma Letter’s Katie Osbo 29 January 2016
Chief executive of Avacta Life Sciences, Alastair Smith, talks to the Pharma Letter about the company's focus on Affirmer binders and their potential applicatio 18 January 2016
If the current trend is any testimony.Indian pharma companies are gradually breaking into the field of research and development to create new molecules.switchin 14 December 2015
India-based Vyome Biosciences plans a regulatory filing by the end of the year with US Food and Drug Administration (FDA) for its lead molecule (VB 1953).which 30 November 2015
With the US Senate launching an investigation into the steep drug price hikes, the ongoing debate on the pharmaceutical industry’s pricing mechanism is once aga 5 November 2015
US health care giant Johnson & Johnson (NYSE: JNJ) is set to launch its drug to treat multiple myeloma in 2016, pending regulatory approvals, Peter Lebowitz, He 23 October 2015
Basilea Pharmaceutica Ltd (SIX: BSLN) plans to start selling Isavuconazole in Europe next year at a price modestly higher than the current market leader voricon 19 October 2015
Ferring Pharma is looking at building a commercial as well as manufacturing headquarters in India over the next 2-3 years, chief operating officer Michael Petti 24 September 2015
Ferring Pharma expects a 20% increase in 2015 full-year revenue on the back of a stronger US dollar, Chief Operating Officer Michel L. Pettigrew, told The Pharm 23 September 2015
Metacure, the medical technology business focussed on diabetes devices, is looking at annual revenue of $20 million following the roll-out of its flagship produ 8 September 2015
Research and drug development collaborations have been a swelling up in the recent months as companies look to pick up strategic partnerships in a bid to expand 2 September 2015
UK drug delivery company SkyePharma has reported robust interim results showing the company’s first half of 2015 operating profits to be 118% ahead year-on-year 26 August 2015
If all goes according to plan, Merck Serono may be looking at two new drug launches in the cancer segment as soon as end-2016, the company’s R&D chief Luciano R 17 August 2015
Rare disease market has renewed interest from the pharma companies as is visible in the heated merger and acquisition activity in the sector. 10 August 2015
Specialist cancer diagnostic medtech company Angle PLC says its loss for the financial year was “deliberate” as it posted a loss from continuing operations of £ 24 July 2015
Doctors without Borders / Médecins Sans Frontières (MSF) on Friday called for the removal of access to medicines provisions in the Trans-Pacific Partnership (TP 24 July 2015
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.